Ventyx Biosciences, Inc. - Common Stock (VTYX)
5.8100
-0.7900 (-11.97%)
NASDAQ · Last Trade: Oct 25th, 8:04 AM EDT
Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.
Via Chartmill · October 24, 2025
Via Benzinga · October 23, 2025
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · October 23, 2025
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · October 23, 2025
Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for VTX3232.
Via Benzinga · October 23, 2025
Via Benzinga · October 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · October 23, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · October 23, 2025
Via Benzinga · October 23, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via Chartmill · October 23, 2025
Via Benzinga · October 23, 2025
Via Benzinga · October 23, 2025
The Phase 2 trial showed VTX3232 cut key inflammation markers like hsCRP by about 78% and IL-6 to below risk thresholds, reinforcing its anti-inflammatory potential.
Via Stocktwits · October 23, 2025
Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.
Via Benzinga · October 23, 2025
Via Benzinga · October 22, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · October 22, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · October 1, 2025
Via Benzinga · September 22, 2025
Via Benzinga · September 5, 2025
Via Benzinga · August 11, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · May 22, 2025
Via Benzinga · May 22, 2025

Sanofi invests $27 million in Ventyx Biosciences at $3.8243 per share. The investment will fund VTX3232 trials for Parkinson's disease.
Via Benzinga · September 23, 2024